Project Details
Description
Mutations in the human KIF1A gene case a novel, rare neurological disease termed KAND. This proposal
is to develop tools for gathering information on patients worldwide, determine how mutations identified in
KIF1A cause neurodegenerative and brain developmental defects, and test novel therapeutic strategies in rat and mouse models.
Status | Finished |
---|---|
Effective start/end date | 2/15/20 → 12/31/22 |
Funding
- National Institute of Neurological Disorders and Stroke: US$577,200.00
- National Institute of Neurological Disorders and Stroke: US$680,466.00
- National Institute of Neurological Disorders and Stroke: US$654,299.00
ASJC Scopus Subject Areas
- Genetics(clinical)
- Clinical Neurology
- Neurology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.